drugset / Trial / NCT02656225

Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome

NCT02656225

RandomizedParallel-groupSingle-blindTreatment

Summary

The prevalence of postpartum anemia is a great threat for maternal and infant health without timely and effective treatment. Oral iron therapy has been used for centuries as a treatment of anemia, however, it is noteworthy that treatment with oral iron might have a limited, and even a harmful role in some clinical scenarios. Ejiao compound is composed with donkey-hide glue, Ginseng, Codonopsis pilosula, prepared rhizome of rehmannia, and crab apple, which has been widely used in the treatment of various types of anemia in China for decades and might be a potentially effective therapy for postpartum anemia. Recently, studies involving animal subjects have helped shed light on its mechanism of action. In this study, the investigators aimed to conduct a randomized controlled trial to assess the efficacy and safety of Ejiao compound comparing with oral iron in the treatment of mild postpartum anemia with or without iron deficiency.

Timeline

Start
2015-03
Primary completion
2016-06
Completion
2016-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ejiao compound Traditional medicine (herbal / TCM) 20 ml Oral
Comparator Polysaccharide iron complex Unknown 150 mg Oral

Indications

No indication recorded.